Hudson Edge Investment Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.83M Sell
87,326
-2,183
-2% -$176K 0.93% 41
2026
Q1
$7.76M Buy
89,509
+14,154
+19% +$1.36M 1.13% 18
2025
Q4
$7.24M Sell
75,355
-5,095
-6% -$495K 1.07% 34
2025
Q3
$7.66M Buy
80,450
+3,344
+4% +$307K 1.24% 18
2025
Q2
$6.72M Buy
77,106
+9,260
+14% +$785K 1.15% 21
2025
Q1
$6.1M Sell
67,846
-7,352
-10% -$658K 1.24% 32
2024
Q4
$6.01M Buy
75,198
+31,054
+70% +$2.69M 1.11% 33
2024
Q3
$3.97M Buy
+44,144
New +$3.71M 0.74% 52

Other funds holding MDT

Hudson Edge Investment Partners's MDT Position: Q2 2026 in Review

Hudson Edge Investment Partners reduced its Medtronic (MDT) stake by 2.4% in Q2 2026, selling an estimated $176K and leaving 87,326 shares worth $6.83M. The position accounts for 0.93% of the portfolio, ranked #41.

Hudson Edge Investment Partners first reported a position in MDT in Q3 2024 and has held it in 8 quarters since. The position peaked at $7.76M in Q1 2026. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Hudson Edge Investment Partners held 87,326 shares of Medtronic worth $6.83M as of Q2 2026.
  • Hudson Edge Investment Partners sold 2,183 Medtronic shares in Q2 2026, an estimated $176K.
  • Medtronic made up 0.93% of Hudson Edge Investment Partners's portfolio in Q2 2026, its #41 holding.
  • Hudson Edge Investment Partners first reported a position in Medtronic in Q3 2024 and has held it in 8 quarters since.
  • Hudson Edge Investment Partners's Medtronic position peaked at $7.76M in Q1 2026.
  • 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Hudson Edge Investment Partners's 13F filing for Q2 2026, filed 29 Jul 2026.